Stay updated on Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.

Latest updates to the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check18 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.7%
- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check61 days agoChange DetectedThe webpage has removed extensive details about a clinical study involving entinostat and pembrolizumab for various cancers, while adding new identifiers and collaborators related to the study.SummaryDifference30%
- Check68 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 20, 2025.SummaryDifference0.1%
- Check75 days agoChange DetectedThe page has updated its posting dates and revision number, indicating a more recent version of the content. The estimated dates have been replaced with specific dates, which may reflect more accurate information.SummaryDifference0.1%
Stay in the know with updates to Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.